Caplight Directory>Companies>Cholesgen Pharmaceutical-preview>Cholesgen


Cholesgen Pharmaceutical

Cholesgen Pharmaceutical

Private
ShanghaiHealthcare & Life Scienceshttps://cholesgen.com/

Last Round

Series A

Extension

Feb 21, 2025

Total Funding Raised

$28M

Company Overview

Cholesgen Pharmaceutical is a biopharmaceutical company that develops innovative drugs for metabolic diseases, such as hyperlipidemia, obesity, diabetes, atherosclerosis, and NASH, as well as oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

drug discoverymetabolic disease therapeuticsfirst-in-class drugsdrug target identificationtarget discoverypharma partnershipspreclinical biotechnologybiotech startupdrug target validationcancer drug discoverybiotech licensinghypercholesterolemiaNASH therapeuticsobesity therapeuticsatherosclerosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cholesgen Pharmaceutical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cholesgen Pharmaceutical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionFeb 21, 2025
Series AJun 6, 2023
SeedApr 1, 2021
View all Funding Rounds

Cholesgen Pharmaceutical Investors

Notable investors and investment history

InvestorRounds
Trinity Innovation FundSeries A, Seed
SDIC Venture CapitalSeries A Extension
AstraZeneca CICC Healthcare Industrial FundSeries A
Gaorong CapitalSeries A
Trinity Innovation FundSeries A
View all Investors

Cholesgen Pharmaceutical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cholesgen Pharmaceutical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cholesgen Pharmaceutical's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Year Founded2021
Last FundingFeb 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.